Clinical Trial

Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
A randomized, multi-site, parallel-group, prospective study of patients who are adults with a diagnosis of mild to moderate open-angle glaucoma (OAG), currently on an on-label use of combination topical medication of Cosopt and Latanoprost for a minimum of 1 month.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-12; most recent amendment 2025-05-14.
Status change: Not Yet Recruiting → Recruiting 2025-05-07
Trial Details
NCT Number NCT06883123
Lead Sponsor Prairie Eye Center
Collaborators: Sengi
Conditions Open Angle Glaucoma
Enrollment 70 participants
Start Date 2025-05-14
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-15